Founded 2002 | Website www.orexigen.com | |
 | ||
Stock price OREX (NASDAQ) US$ 3.98 -0.02 (-0.50%)24 Mar, 4:00 PM GMT-4 - Disclaimer Headquarters La Jolla, California, United States Founders Michael Cowley, John Francis Crowley, Eckard Weber | ||
orex orexigen therapeutics inc independent analysis
Orexigen Therapeutics is a public American pharmaceutical company focused on development of treatments for obesity. The company is based in La Jolla, California and was established by Eckard Weber in 2002. As a public company, Orexigen is traded on the NASDAQ exchange under the stock symbol OREX. The company has a single product, Contrave, approved for use in the United States in 2014. The launch of Contrave was conducted through a sales force of 900. Observation of the market performance of Qsymia and Belviq suggest overall low demand for pharmaceutical obesity therapies, calling into question earnings potential for Orexigen's offering.
Contents
- orex orexigen therapeutics inc independent analysis
- News update shares of orexigen therapeutics inc orex plummet
- References
News update shares of orexigen therapeutics inc orex plummet
References
Orexigen Therapeutics Wikipedia(Text) CC BY-SA